- Investing Ideas
- Belgian Pharmaceuticals & Biotech Large Cap High Growth Potential
Belgian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
argenx
Market Cap: €47.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€760.20
7D
-0.1%
1Y
56.1%
UCB
Market Cap: €45.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€243.90
7D
4.9%
1Y
41.4%